Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Taxane-induced Peripheral Neuropathy 1Sarcopenia 1Peripheral Nervous System Diseases 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Gloves, Surgical × Clear all
NCT07285356 2025-12-16

GLOX-PEN

AC Camargo Cancer Center

Phase NA Recruiting
84 enrolled
Gastrointestinal

Colonic Neoplasms, Peripheral Nervous System Diseases, Sarcopenia

NCT06464536 2025-05-16

ComPrendo

St.Gallen University of Applied Sciences

Phase NA Recruiting
114 enrolled

Taxane-induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡